Merck cut a drug discovery cycle by 33% and ships compliant marketing 80% faster. Mastercard is rethinking fraud disputes.

CBSE has denied that the actual evaluation portal was compromised, saying the vulnerabilities highlighted by the teenager related only to a “testing site”.

In 2026, several federal cases are poised to shape regulatory risk, reimbursement, and False Claims Act exposure, as well as innovation ...